All the results sufficiently consolidated that suppressing shedding of SDC1 could alleviate the inflammatory response, partially via inhibiting NF-κB pathway and TNF-α, which are consistent with the decreased level of SDC1 in mucosa but increased level of its ectodomain in serum in patients with Crohn's disease [6]. The gene discussed is SDC1; the disease is Crohn disease.